Advertisement Dow Sells Of Morton For $1.675 Billion - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Dow Sells Of Morton For $1.675 Billion

To pay bridge loan used to fund acquisition of Rohm and Haas

The Dow Chemical sells its interest in Morton International to K+S Aktiengesellschaft for $1.675 billion.

The company said that approximately one billion dollars in proceeds from this transaction will be used to pay the outstanding balance of a bridge loan that it used to partially fund its acquisition of Rohm and Haas earlier this year.

The remaining proceeds, as well as proceeds from future non-strategic definitive divestiture agreements already in place, will be used to pay down other debt, in-line with the company’s broader deleveraging plan.

Andrew Liveris, chairman and CEO of Dow, said: “With this transaction, we have accomplished our objective of fully paying off the bridge loan and eliminating this financing facility. We accomplished this well ahead of our year-end goal, and we remain ahead of schedule on all other financial milestones related to the Rohm and Haas acquisition.”